Results 31 to 40 of about 2,077 (188)

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

International Journal of Women's Health, 2009
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, S Kellogg, M Krychman
doaj   +1 more source

Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception

Gynecological Endocrinology, 2023
The objective is to assess the perception of gynecologists regarding patients' adherence to vulvovaginal atrophy (VVA) treatments, to evaluate the gynecologists' opinions on what their patients think about treatment adherence, and to compare the gynecologists' opinions with the patients' own perceptions within the CRETA study.Spanish gynecologists who ...
María J. Cancelo, Rafael Sánchez Borrego, Santiago Palacios, Laura Baquedano, Tanit Corbacho Garza, Noelia Fernández Aller, Carmen García Ferreiro, Juan José Quijano Martín, A. Javier González Calvo   +8 more
openaire   +4 more sources

Vulvovaginal atrophy during menopause [PDF]

, 2017
Objective: To present a basic clinical research based on current evidence about advanced treatment methods for vulvovaginal atrophy during menopause.And on principles of management of patients with vulvovaginal atrophy.Vulvovaginal atrophy (VVA) is a common and underreported condition associated with decreased estrogenization of the vaginal tissue ...
Orru, A.J.
openaire   +2 more sources

Barriers to effective treatment of vaginal atrophy with local estrogen therapy

International Journal of General Medicine, 2013
Suzanne ReiterMid-County Health Center, Largo, FL, USAAbstract: Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary
Reiter S
doaj   +1 more source

Vulvovaginal atrophy: issues of treatment and rehabilitation: A review [PDF]

Гинекология, 2022
The review presents data on the management tactics of women with vulvovaginal atrophy in patients of reproductive age and menopause. The influence of vulvovaginal atrophy on the psycho-emotional and sexual spheres, modern methods of diagnosis and therapy
Diana M. Ampilogova, Antonina G. Solopova, Dmitry V. Blinov, Evgeny E. Achkasov, Daria A. Petrenko, Daniil I. Korabelnikov   +5 more
doaj   +1 more source

The Role of Topical Treatment on Vaginal Tightening

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2022
Background: Physiological changes in a woman's life, such as labor, weight fluctuations, hormonal changes, aging, and menopause, cause changes in both appearance and function of the vagina.
Made Putri Hendaria
doaj   +1 more source

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

Menopause Review, 2021
During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep.
Wojciech Pięta, Roman Smolarczyk
doaj   +1 more source

Multifaceted Impact of CO₂ Laser Therapy on Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy and Sexual Function. [PDF]

Healthcare (Basel)
Genitourinary syndrome of menopause (GSM) encompasses a range of distressing symptoms in the vulvovaginal and/or bladder–urethral regions related to menopause changes, negatively influencing woman’s quality of life and sexual activity ...
Jankovic S, Rovcanin M, Zamurovic M, Jovanovic B, Raicevic T, Tomic A.   +5 more
europepmc   +2 more sources

Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy

, 2021
Vulvovaginal atrophy is frequent, can be bothersome and can impair quality of life in postmenopausal women. The main objective of this prospective, randomized study was to compare the acceptability of low-dose vaginal 17β-estradiol (estradiol) tablets ...
S. Palacios (810500), M. Ramirez (5915972), M. Lilue (11747345)   +2 more
core   +1 more source

Comparative assessment of local immunity in patients with vulvovaginal atrophy: An observational cohort study

Кубанский научный медицинский вестник
Background. Vulvovaginal atrophy is a chronic, progressive condition associated with estrogen deficiency. While involutional changes are well-documented, the relationship between the vaginal microbiota and the local immune response in vulvovaginal ...
M. I. Biryukova, E. I. Kravtsova, I. I. Kutsenko   +2 more
doaj   +1 more source